Literature DB >> 19583449

Viral myocarditis: diagnosis, aetiology and management.

Uwe Kühl1, Heinz-Peter Schultheiss.   

Abstract

Myocarditis is an inflammatory disease of the cardiac muscle caused by myocardial infiltration of immunocompetent cells following any kind of cardiac injury. Classic myocarditis mainly occurs as a result of the host's immune response against organisms that cause common infectious illnesses, as a manifestation of hypersensitivity or as a toxic reaction to drug therapy. Chronic inflammatory events may survive successful clearance of initial cardiotoxic agents, be triggered or amplified by autoimmunological processes, or develop in the context of systemic diseases. If the underlying infectious or immune-mediated causes of the disease are carefully defined by clinical and biopsy-based tools, specific immunosuppressive and antiviral treatment options may improve the prognosis of patients with acute and chronic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19583449     DOI: 10.2165/00003495-200969100-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  87 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).

Authors:  Naoyoshi Aoyama; Tohru Izumi; Katsuhiko Hiramori; Mitsuaki Isobe; Masatoshi Kawana; Michiaki Hiroe; Hitoshi Hishida; Yasushi Kitaura; Tsutomu Imaizumi
Journal:  Circ J       Date:  2002-02       Impact factor: 2.993

3.  In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease.

Authors:  R Kandolf; D Ameis; P Kirschner; A Canu; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.

Authors:  Stephane Heymans; Matthias Pauschinger; Armando De Palma; Angela Kallwellis-Opara; Susanne Rutschow; Melissa Swinnen; Davy Vanhoutte; Fangye Gao; Raimund Torpai; Andrew H Baker; Elisabeth Padalko; Johan Neyts; Heinz-Peter Schultheiss; Frans Van de Werf; Peter Carmeliet; Yigal M Pinto
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

5.  Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

Authors:  Nikos Papadogiannakis; Thomas Tolfvenstam; Björn Fischler; Oscar Norbeck; Kristina Broliden
Journal:  Clin Infect Dis       Date:  2002-10-11       Impact factor: 9.079

6.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

7.  Viral myocarditis mimicking acute myocardial infarction.

Authors:  G W Dec; H Waldman; J Southern; J T Fallon; A M Hutter; I Palacios
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

8.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

9.  Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens.

Authors:  P Muir; F Nicholson; M Jhetam; S Neogi; J E Banatvala
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

10.  Subclassification of dilated cardiomyopathy and interferon treatment.

Authors:  M Stille-Siegener; A Heim; H R Figulla
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

View more
  10 in total

1.  Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.

Authors:  Steven E Lipshultz; Paige L Williams; Bret Zeldow; James D Wilkinson; Kenneth C Rich; Russell B van Dyke; George R Seage; Laurie B Dooley; Jonathan R Kaltman; George K Siberry; Lynne M Mofenson; William T Shearer; Steven D Colan
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

2.  Cardiac biomarkers in HIV-exposed uninfected children.

Authors:  James D Wilkinson; Paige L Williams; Erin Leister; Bret Zeldow; William T Shearer; Steven D Colan; George K Siberry; Laurie B Dooley; Gwendolyn B Scott; Kenneth C Rich; Steven E Lipshultz
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

3.  Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.

Authors:  S Van Linthout; K Savvatis; K Miteva; J Peng; J Ringe; K Warstat; C Schmidt-Lucke; M Sittinger; H-P Schultheiss; C Tschöpe
Journal:  Eur Heart J       Date:  2010-12-22       Impact factor: 29.983

4.  Acute myocarditis mimicking ST-elevation myocardial infarction: A case report and review of the literature.

Authors:  Tao Zhang; Wei Miao; Shixuan Wang; Min Wei; Guohai Su; Zhenhua Li
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

5.  Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.

Authors:  Christine S Siegismund; Maria Rohde; Uwe Kühl; Felicitas Escher; Heinz Peter Schultheiss; Dirk Lassner
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-07-28       Impact factor: 7.691

6.  Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis.

Authors:  Zhuang Zhuang; Zi-Hao Wang; Li-Hui Deng; Qun Zheng; Guo-Qing Zheng; Yan Wang
Journal:  Front Pharmacol       Date:  2019-11-28       Impact factor: 5.810

7.  Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.

Authors:  Sabine Ameling; Gourav Bhardwaj; Elke Hammer; Daniel Beug; Leif Steil; Yvonne Reinke; Kerstin Weitmann; Markus Grube; Christiane Trimpert; Karin Klingel; Reinhard Kandolf; Wolfgang Hoffmann; Matthias Nauck; Marcus Dörr; Klaus Empen; Stephan B Felix; Uwe Völker
Journal:  Basic Res Cardiol       Date:  2016-07-13       Impact factor: 17.165

8.  Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice.

Authors:  Yimin Xue; Mingguang Chen; Qian Chen; Tingfeng Huang; Qiaolian Fan; Fenghui Lin; Jun Ke; Feng Chen
Journal:  Virol J       Date:  2021-11-14       Impact factor: 4.099

9.  Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.

Authors:  Sabine Ameling; Lars R Herda; Elke Hammer; Leif Steil; Alexander Teumer; Christiane Trimpert; Marcus Dörr; Heyo K Kroemer; Karin Klingel; Reinhard Kandolf; Uwe Völker; Stephan B Felix
Journal:  Eur Heart J       Date:  2012-10-25       Impact factor: 29.983

10.  Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.

Authors:  Hengshan Zhu; Chuang Lou; Ping Liu
Journal:  Virol J       Date:  2015-11-14       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.